Research and Development of the New Antiviral Drugs by Remodeling of the New Diterpenoid Isolated from Sea Algae

海藻新二萜改造研发新型抗病毒药物

基本信息

项目摘要

In the screening study for investigation of a new antiviral compound, the authors found the chromene derivative 1 from the brown alga Sargassum micracanthum along with some known plastoquinones. More careful isolation revealed compound 1 possessing a strong antiviral activity against HSV,HIV and HCMV to be an artifact, converted from the known plastoquinones in the isolation process ; however, these plastoquinones did not show antiviral effect even for HSV-1. The authors started to find much more active compound similar to 1 by SAR method, including the remodeling of chromene 1,polymer-supported derivatives and the analogs of 1 hybridized with some delivery peptides. Totally twelve analogs were synthesized from the plastoquinones and commercially available simple compounds. According to the bioassay of them, four chromenes converted from the known plastoquinones showed strong antiviral activity against HSV-1,HSV-2,HCMV, Influenza and HIV as much as that of 1. Moderate antiviral activity against HSV was observed from the remaining eight compounds in vitro. According to the data, the chromene structure is the crucial for expressing the antiviral activity. These chromenes might be inhibited reverse-transcriptase (RT) and some chemokine receptor such as CCR5 in the primitive analysis of HIV infection. The activity of polymer-supported chromenes were still under investigation. In addition, the author continued to find the new bioactive compounds from algae. Four new antioxidative plastoquinones related the above-mentioned ones were isolated from S.micracanthum. Unfortunately, these new compounds did not exhibit antiviral effect. From the other brown algae related S.micracanthum, a lot of known compounds were obtained such as antioxidative carotenoids (a kind of fucoxanthine), cytotoxic terpenoids and fatty acid derivatives (glycerides and oxylipins). These results were already published, and see the references and patent.
在研究新型抗病毒化合物的筛选研究中,作者发现了来自褐藻马尾藻的色烯衍生物 1 以及一些已知的质体醌。更仔细的分离表明,对 HSV、HIV 和 HCMV 具有强抗病毒活性的化合物 1 是一种人工产物,是在分离过程中由已知的质体醌转化而来的;然而,这些质体醌甚至对 HSV-1 也没有表现出抗病毒作用。作者开始通过SAR方法寻找活性更高的类似于1的化合物,包括色烯1的重构、聚合物支持的衍生物以及与一些递送肽杂交的1的类似物。由质体醌和市售简单化合物合成了总共十二种类似物。根据它们的生物测定,由已知质体醌转化的四种色烯对HSV-1、HSV-2、HCMV、流感和HIV表现出与1一样强的抗病毒活性。其余八种化合物在体外观察到对HSV的中等抗病毒活性。数据显示,色烯结构对于表达抗病毒活性至关重要。在 HIV 感染的原始分析中,这些色烯可能会抑制逆转录酶 (RT) 和一些趋化因子受体(例如 CCR5)。聚合物支持的色烯的活性仍在研究中。此外,作者还继续从藻类中寻找新的生物活性化合物。从S.micracanthum 中分离出四种与上述相关的新的抗氧化质体醌。不幸的是,这些新化合物没有表现出抗病毒作用。从其他褐藻相关的S.micracanthum中,获得了许多已知的化合物,如抗氧化类胡萝卜素(一种岩藻黄质)、细胞毒性萜类化合物和脂肪酸衍生物(甘油酯和氧脂素)。这些结果已经发表,请参阅参考文献和专利。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
新規クロメン化合物
新型色烯化合物
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A Synthetic Study on Antiviral and Antioxidative Chromen Derivative.
抗病毒和抗氧化铬衍生物的综合研究。
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawauchi;et. al.;Nishimura et al.;Dezawa et al.;Yoshizawa et al.;星野 幹雄;星野 幹雄
  • 通讯作者:
    星野 幹雄
Effects of Plastoquinones from the Brown Alga Sargassum micracanthum and a New Chromene Derivative Converted from the Plastoquinones on Acute Gastric Lessions in Rats.
褐藻马尾藻质体醌和质体醌转化的新色烯衍生物对大鼠急性胃损伤的影响。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J.Mori;T.Hayashi;M.Iwashima;T.Matsunaga;H.Saito
  • 通讯作者:
    H.Saito
New plastoquinones isolated from the brown alga, Sargassum micracanthum
  • DOI:
    10.1248/cpb.53.1159
  • 发表时间:
    2005-09-01
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Mori, J;Iwashima, M;Hayashi, T
  • 通讯作者:
    Hayashi, T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IWASHIMA Makoto其他文献

IWASHIMA Makoto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry
宿主和肠道微生物介导的代谢对接骨木浆果抗病毒活性的贡献
  • 批准号:
    10723102
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
Identification and characterization of the human factors targeted by the Nucleic Acid Polymers (NAP) responsible for its antiviral activity against HBV and HDV.
核酸聚合物(NAP)针对 HBV 和 HDV 抗病毒活性的人为因素的鉴定和表征。
  • 批准号:
    558342-2020
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Alliance Grants
Contributions of host and gut microbial mediated metabolism to the antiviral activity of elderberry
宿主和肠道微生物介导的代谢对接骨木浆果抗病毒活性的贡献
  • 批准号:
    10537933
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
Development of new visible light responsive organic semiconductor photocatalyst and its evaluation of antibacterial and antiviral activity
新型可见光响应有机半导体光催化剂的研制及其抗菌抗病毒活性评价
  • 批准号:
    22K04827
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
  • 批准号:
    10258146
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Mechanism of Light-activated Antiviral Activity of Conjugated Polyelectrolyte Polymers and Oligomers
共轭聚电解质聚合物和低聚物的光激活抗病毒活性机制
  • 批准号:
    2105171
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Continuing Grant
Identification and characterization of the human factors targeted by the Nucleic Acid Polymers (NAP) responsible for its antiviral activity against HBV and HDV.
核酸聚合物(NAP)针对 HBV 和 HDV 抗病毒活性的人为因素的鉴定和表征。
  • 批准号:
    558342-2020
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Alliance Grants
Antiviral Activity In Situ
原位抗病毒活性
  • 批准号:
    10475294
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
  • 批准号:
    10670229
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
抗体效应子功能多样性对原位抗病毒活性的影响
  • 批准号:
    10475274
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了